The samples will be collected in one database; This will help overcome Russia’s dependence on importing reference samples of pharmaceutical products, according to the government website.
The relevant decree was signed by Russia’s Prime Minister Mikhail Mishustin.
“Reference samples are needed to compare the active ingredients of drugs at all stages of industrial production. The creation of their database will help overcome Russia’s dependence on importing standardized samples of pharmaceutical products and control the quality of essential and essential drugs at all stages of circulation, ”the message says.
It is noted that thanks to state support, it is planned to start work on the development of at least 300 drug samples this year. In the first stage, 300 million rubles will be allocated for these purposes.
The signed resolution is part of the priority action plan to ensure the development of the sanctioned Russian economy, the government explained, reports Interfax.
.
